AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34501915 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation (PSG)
Number of subjects: 90
Study 34210187 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction condition (distracting concurrent task)
Number of subjects: 0
Study 34210187 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no distracting task)
Number of subjects: 0
Study 33139038 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA-enriched diet
Number of subjects: 57
Study 33139038 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital meals (Control)
Number of subjects: 57
Study 32238920 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 response-guided arm (Ki-67 arm)
Number of subjects: 237
Study 32238920 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard chemotherapy)
Number of subjects: 237
Study 35157835 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib plus standard of care
Number of subjects: 0
Study 35157835 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 0
Study 35970681 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl patches (TFP)
Number of subjects: 48
Study 35970681 — intervention group
Group type: COMPARATOR
Intervention: Non-opioid analgesics (NSAIDs)
Number of subjects: 48
Study 33058773 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBMT) using a neodymium‐doped YAG (Nd: YAG) laser
Number of subjects: 20
Study 33058773 — intervention group
Group type: COMPARATOR
Intervention: Control (no PBMT)
Number of subjects: 20
Study 36141665 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Program for Early Childhood Development (comprehensive early development interventions via bi-weekly home visiting activities and monthly family group activities)
Number of subjects: 0
Study 36141665 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Program for Early Childhood Development
Number of subjects: 0
Study 34189864 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment for 8 weeks
Number of subjects: 96
Study 34189864 — intervention group
Group type: COMPARATOR
Intervention: Sham moxibustion treatment for 8 weeks
Number of subjects: 96
Study 34189864 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 35017774 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of dexmedetomidine
Number of subjects: 81
Study 35017774 — intervention group
Group type: EXPERIMENTAL
Intervention: Late administration of dexmedetomidine
Number of subjects: 81
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction at M12
Number of subjects: 54
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction Scores at M12
Number of subjects: 54
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge Eating at M12
Number of subjects: 54
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction Prevalence
Number of subjects: 54
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge Eating Prevalence Pre-surgery
Number of subjects: 54
Study 33000357 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction Prevalence Pre-surgery
Number of subjects: 54
Study 34910080 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted prevention intervention including structured delirium education, daily assessment of delirium risk factors, and tailored prevention strategies (cognitive, motor, sensory stimulation, etc.)
Number of subjects: 1470
Study 34910080 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1470
Study 34910080 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted prevention intervention
Number of subjects: 1470
Study 32602445 — intervention group
Group type: EXPERIMENTAL
Intervention: DCDQ-ES (Developmental Coordination Disorder Questionnaire - European Spanish version)
Number of subjects: 31
Study 35190292 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezacaftor/ivacaftor
Number of subjects: 130
Study 34029650 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical hand scrub with nail brush for 2 minutes (Group III)
Number of subjects: 180
Study 34029650 — intervention group
Group type: COMPARATOR
Intervention: Surgical hand scrub without nail brush for 2 minutes (Group IV)
Number of subjects: 180
Study 34029650 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical hand scrub with nail brush for 1 minute (Group I)
Number of subjects: 180
Study 34029650 — intervention group
Group type: COMPARATOR
Intervention: Surgical hand scrub without nail brush for 1 minute (Group II)
Number of subjects: 180
Study 34913487 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Family Therapy (MFT) for 3 months
Number of subjects: 76
Study 35715802 — intervention group
Group type: EXPERIMENTAL
Intervention: Gracey Curette
Number of subjects: 120
Study 35715802 — intervention group
Group type: EXPERIMENTAL
Intervention: After Five Curette
Number of subjects: 120
Study 35715802 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Five Curette
Number of subjects: 120
Study 35715802 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 32572020 — intervention group
Group type: EXPERIMENTAL
Intervention: 40IU self‐administered intranasal oxytocin (OT)
Number of subjects: 30
Study 32572020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35157053 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Treatment Study (remote trial)
Number of subjects: 1410
Study 35157053 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote trial online recruitment
Number of subjects: 1410
Study 33638020 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 160
Study 33638020 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided PCNL
Number of subjects: 160
Study 32163509 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy (BBAT) plus Treatment as Usual (TAU)
Number of subjects: 338
Study 32163509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed Physical Activity (MPA) plus Treatment as Usual (TAU)
Number of subjects: 338
Study 32163509 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 338
Study 32449418 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clobetasol plus oral low dose naltrexone (3 mg)
Number of subjects: 34
Study 32449418 — intervention group
Group type: COMPARATOR
Intervention: Topical clobetasol plus placebo
Number of subjects: 34
Study 32449418 — intervention group
Group type: COMPARATOR
Intervention: Comparison between LDN and placebo
Number of subjects: 34
Study 32449418 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose naltrexone (3 mg)
Number of subjects: 34
Study 33771664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 33771664 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 33771664 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib/Trametinib
Number of subjects: 0
Study 33771664 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab and Nivolumab (combined therapy)
Number of subjects: 0
Study 33771664 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Ipilimumab
Number of subjects: 0
Study 35947455 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw fixation (2 x 3.5‐mm partially threaded cannulated screws)
Number of subjects: 10
Study 35947455 — intervention group
Group type: COMPARATOR
Intervention: Suture button fixation (2 surgical buttons)
Number of subjects: 10
Study 34816053 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand auditory cueing and instructions
Number of subjects: 62
Study 34816053 — intervention group
Group type: COMPARATOR
Intervention: Feedback about physical activity using the wearable DeFOG system
Number of subjects: 62
Study 35872584 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Isoniazid 15 mg/kg and rifapentine 750/900 mg weekly for 8 weeks.
Number of subjects: 2583
Study 35872584 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: Isoniazid [600-(50-body weight)×15] (rounded up) and rifapentine 600/450 mg twice a week for 6 weeks.
Number of subjects: 2583
Study 33945885 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm storage device with training (offered at no or low cost)
Number of subjects: 256
Study 33945885 — intervention group
Group type: COMPARATOR
Intervention: Usual care (observation phase)
Number of subjects: 256
Study 33945885 — intervention group
Group type: EXPERIMENTAL
Intervention: Firearm storage device with training (among those not practicing TSS at baseline)
Number of subjects: 256
Study 34687290 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast framing
Number of subjects: 284
Study 34687290 — intervention group
Group type: COMPARATOR
Intervention: Connect framing
Number of subjects: 284
Study 34687290 — intervention group
Group type: COMPARATOR
Intervention: Neutral framing
Number of subjects: 284
Study 32421229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) treatment
Number of subjects: 50
Study 35978435 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal shift-work intervention including healthy scheduling, education program, and information campaign for shift planners.
Number of subjects: 160
Study 33118716 — intervention group
Group type: EXPERIMENTAL
Intervention: rFSH
Number of subjects: 168
Study 33118716 — intervention group
Group type: COMPARATOR
Intervention: hMG
Number of subjects: 168
Study 32865576 — intervention group
Group type: EXPERIMENTAL
Intervention: Student Bodies‐Eating Disorders, a digital CBT‐guided self‐help program
Number of subjects: 690
Study 32865576 — intervention group
Group type: COMPARATOR
Intervention: Referral to usual care
Number of subjects: 690
Study 35559249 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF) 2,400 mg daily during prevention cycles
Number of subjects: 120
Study 35559249 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF) during acute episodes
Number of subjects: 120
Study 35559249 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea purpurea extract (Echinaforce®, EF)
Number of subjects: 120
Study 35559249 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 32383347 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised printed and mobile-accessible discharge instructions
Number of subjects: 80
Study 32383347 — intervention group
Group type: COMPARATOR
Intervention: Usual pain relief discharge advice
Number of subjects: 80
Study 33558721 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ipilimumab plus nivolumab
Number of subjects: 95
Study 33558721 — intervention group
Group type: EXPERIMENTAL
Intervention: High tumor mutational burden (TMB) and high interferon-gamma-related gene expression signature score (IFN-γ score)
Number of subjects: 95
Study 33558721 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant therapy with antibodies against PD-1 (proposed for future study)
Number of subjects: 95
Study 32473649 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine + Propofol (L + P)
Number of subjects: 79
Study 32473649 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline + Propofol (NS + P)
Number of subjects: 79
Study 35527573 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency nursing and monitoring procedure
Number of subjects: 134
Study 35527573 — intervention group
Group type: COMPARATOR
Intervention: Normal nursing procedure
Number of subjects: 134
Study 33026551 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic cartilage segmentation using KneeCaP software
Number of subjects: 91
Study 33026551 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 91
Study 33026551 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild‐to‐moderate OA group
Number of subjects: 91
Study 33026551 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe OA group
Number of subjects: 91
Study 33026551 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild‐to‐moderate OA group vs Severe OA group
Number of subjects: 91
Study 33006191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy (10.12 MJ/kg)
Number of subjects: 36
Study 33006191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy (10.90 MJ/kg)
Number of subjects: 36
Study 33006191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy (11.68 MJ/kg)
Number of subjects: 36
Study 33006191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy (varied)
Number of subjects: 36
Study 36135037 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (EX)
Number of subjects: 28
Study 36135037 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 28
Study 36135037 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training during AC taper week
Number of subjects: 28
Study 36135037 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized exercise approach
Number of subjects: 28
Study 34915907 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with higher reverse T3 (rT3) compared to controls (p=0.0002)
Number of subjects: 436
Study 34915907 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with lower T3/rT3 compared to controls (p=0.0012)
Number of subjects: 436
Study 34915907 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients had higher IGFBP3 compared to controls (p=0.030)
Number of subjects: 436
Study 34915907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower T3/rT3 associated with lower handgrip strength and shorter 6-min walk distance (p≤0.036)
Number of subjects: 436
Study 34915907 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher IGFBP3 associated with higher handgrip strength (p=0.031)
Number of subjects: 436
Study 34915907 — intervention group
Group type: COMPARATOR
Intervention: Comparable serum concentrations of thyroid hormones and binding proteins between patients and controls
Number of subjects: 436
Study 34915907 — intervention group
Group type: COMPARATOR
Intervention: Comparable concentrations of growth hormone, IGF-I, and IGFBP1 between patients and controls
Number of subjects: 436
Study 34915907 — intervention group
Group type: COMPARATOR
Intervention: Comparable total and free cortisol, cortisol-binding globulin, and albumin concentrations between patients and controls
Number of subjects: 436
Study 36407843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone/Naloxone Prolonged Release (OXN PR)
Number of subjects: 0
Study 36407843 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone Prolonged Release (Oxy PR)
Number of subjects: 0
Study 32272281 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based multimodal nursing program plus routine nursing care for 6 months
Number of subjects: 111
Study 32272281 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 111
Study 34510077 — intervention group
Group type: EXPERIMENTAL
Intervention: Measuring group (pedicle measuring technique)
Number of subjects: 389
Study 34510077 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional DIEP flap technique)
Number of subjects: 389
Study 33075179 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (100 mg/kg TID)
Number of subjects: 68
Study 33075179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 32493211 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified dose of 0.5% isobaric bupivacaine in group U
Number of subjects: 60
Study 32493211 — intervention group
Group type: COMPARATOR
Intervention: 2 ml of 0.5% isobaric bupivacaine in group C
Number of subjects: 60
Study 36015163 — intervention group
Group type: EXPERIMENTAL
Intervention: Kan Jang® (daily dose of andrographolides—90 mg)
Number of subjects: 86
Study 36015163 — intervention group
Group type: EXPERIMENTAL
Intervention: Kan Jang®
Number of subjects: 86
Study 33741696 — intervention group
Group type: EXPERIMENTAL
Intervention: IADPSG criteria for diagnosing GDM
Number of subjects: 0
Study 33741696 — intervention group
Group type: EXPERIMENTAL
Intervention: Response to treatment at different diagnostic thresholds of maternal glycemia
Number of subjects: 0
Study 36078296 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HEX) at 80% 1-RM
Number of subjects: 40
Study 36078296 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-moderate-intensity resistance training (LEX) at 50% 1-RM
Number of subjects: 40
Study 36078296 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 40
Study 34217283 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 168
Study 34217283 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 168
Study 35057841 — intervention group
Group type: EXPERIMENTAL
Intervention: Near real-time data-driven recruitment approach using NHS Test and Trace service
Number of subjects: 2639
Study 35057841 — intervention group
Group type: EXPERIMENTAL
Intervention: Public consultation regarding the use of test data for recruitment
Number of subjects: 2639
Study 34469857 — intervention group
Group type: EXPERIMENTAL
Intervention: RAY (Rhythms And You)
Number of subjects: 47
Study 34469857 — intervention group
Group type: EXPERIMENTAL
Intervention: RAY-CH (RAY with clinical helper support)
Number of subjects: 47
Study 34469857 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive Reading Material (ARM)
Number of subjects: 47
Study 34469857 — intervention group
Group type: EXPERIMENTAL
Intervention: RAY-CH
Number of subjects: 47
Study 34469857 — intervention group
Group type: EXPERIMENTAL
Intervention: RAY
Number of subjects: 47
Study 34349181 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium intake (mean 24-h sodium excretion of 3834 mg)
Number of subjects: 582
Study 34349181 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric intake
Number of subjects: 582
Study 34349181 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight/obese with hypertension
Number of subjects: 582
Study 32114617 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium
Number of subjects: 73
Study 32114617 — intervention group
Group type: COMPARATOR
Intervention: No Delirium
Number of subjects: 73
Study 35841202 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 2321
Study 34127107 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/d)
Number of subjects: 306
Study 32878606 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection time < 180 s
Number of subjects: 70
Study 32878606 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection time 180-300 s
Number of subjects: 70
Study 32878606 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection time > 300 s
Number of subjects: 70
Study 32878606 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 70
Study 33152542 — intervention group
Group type: EXPERIMENTAL
Intervention: Saroglitazar
Number of subjects: 0
Study 33152542 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 33667460 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Serratus Anterior Plane Block (SAPB) in combination with intravenous flurbiprofen
Number of subjects: 0
Study 33667460 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (Control)
Number of subjects: 0
Study 34548341 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulable speed group (operators can choose ultrasound speed: 1420, 1480, or 1540 m/s)
Number of subjects: 0
Study 34548341 — intervention group
Group type: COMPARATOR
Intervention: Conventional speed group (ultrasound speed fixed at 1540 m/s)
Number of subjects: 0
Study 35809105 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial congruent (MC) bearing
Number of subjects: 66
Study 35809105 — intervention group
Group type: COMPARATOR
Intervention: Patient-reported outcome measures
Number of subjects: 66
Study 35809105 — intervention group
Group type: COMPARATOR
Intervention: Clinical characteristics
Number of subjects: 66
Study 33315415 — intervention group
Group type: EXPERIMENTAL
Intervention: Candidate-heterogeneous displays (equal numbers of high- and low-similarity candidates)
Number of subjects: 0
Study 33315415 — intervention group
Group type: EXPERIMENTAL
Intervention: Lures added a response time cost
Number of subjects: 0
Study 33124563 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist's educational interview at baseline
Number of subjects: 89
Study 33124563 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational interview until month 6)
Number of subjects: 89
Study 33124563 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study 32766199 — intervention group
Group type: EXPERIMENTAL
Intervention: FCHV capacity building and mobile phone text messaging to expectant mothers
Number of subjects: 413
Study 32766199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 413
Study 34288639 — intervention group
Group type: COMPARATOR
Intervention: Sugammadex
Number of subjects: 181
Study 34288639 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine/glycopyrrolate
Number of subjects: 181
Study 32197933 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical hyaluronic acid (HA) 40 mg (Hyacyst®) weekly for 4 weeks, then monthly for 3 months
Number of subjects: 20
Study 35810525 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter yoga (8 sessions over 4 weeks, twice a week)
Number of subjects: 101
Study 35810525 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 101
Study 34840600 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy (10 units per 10 cm² of wound, injected in 1 mL 0.9% saline)
Number of subjects: 346
Study 34840600 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing with normal saline (Control)
Number of subjects: 346
Study 33040106 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom (Group A)
Number of subjects: 40
Study 33040106 — intervention group
Group type: COMPARATOR
Intervention: Traditional demonstration method (Group B)
Number of subjects: 40
Study 34403911 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 intravenously on day 1 every 21 days
Number of subjects: 45